California-based biotech Cytokinetcs ( CYTK 4.56%) finished the trading week in style, as its stock price outperformed many ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

The treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for patients ...

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...

Sanofi ( (SNY) ) has issued an announcement.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

Cytokinetics (CYTK) announced that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten from Corxel ...

The Langerhans cell histiocytosis management market is expected to grow at a value of 5% CAGR in the forecast period ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

Sanofi and Regeneron are in the process of testing out blockbuster biologic Dupixent in the indication, for one, and clinical ...

The dengue viruses primarily circulate in the tropics and subtropics and are transmitted to people by infected mosquitoes. There are an estimated 400 million infections every year making about 100 ...

A multiyear drought in M&A has left Wall Street banks at the mercy of private equity firms, who are now calling the shots in ...

Significant players in the Venous Ulcer Treatment market are Angiodynamics, Sigvaris Global, Medi GmbH & Co. KG, Activa ...